EndoChoice

Based near Atlanta GA, EndoChoice is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the revolutionary Full Spectrum Endoscopy System (Fuse). 2014 marked the fifth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine.

Type
Public
HQ
Alpharetta, US
Founded
2008
Employees
328 (est)-1%
EndoChoice was founded in 2008 and is headquartered in Alpharetta, US

EndoChoice Locations

Alpharetta, US

EndoChoice Metrics

EndoChoice Summary

Market capitalization

$208 M

Closing share price

$8
EndoChoice's latest market capitalization is $208 M.

EndoChoice Market Value History

EndoChoice Online Presence

EndoChoice Company Life

You may also be interested in